Critique of Dr. Diane Harper’s Comments on Gardasil
By Judy Wilyman
PhD Candidate
Murdoch University
Dr. Diane Harper is a researcher who was involved in the safety and efficacy
trials for the Human Papillomavirus (HPV) vaccine – Gardasil®. This drug is
observed to prevent infection from 2 strains of HPV virus (16 and 18) and it has
been promoted to the public as being preventative against cervical cancer. The
clinical trials for this drug were funded by the pharmaceutical company Merck
and many of the researchers were employed by Merck (1). On the 19th August Dr.
Harper spoke out about the concerns she has regarding the safety of this drug
and its ability to prevent cervical cancer. She is to be commended for doing
this and her comments have been presented in a CBS media release titled
Gardasil® Vaccine causes More Deaths and Damage than the Vaccine itself (2). As
a parent and a researcher, I have been compelled to write the following article
about Dr. Harper’s comments because it is apparent that the public has been
misinformed about this drug.
Dr Diane Harper, a lead researcher in the development
of the humanpapilloma virus vaccine
In the interview Dr. Harper gave to CBS she stated that she believes “the public
should receive more complete warnings before receiving the vaccine”. This is
incorrectly stating the problem. Instead of ‘more complete warnings’ I believe
it is extremely important that parents are given accurate information on
Gardasil®. This drug has been promoted as a cervical cancer drug when in fact it
has only been observed to prevent HPV infection (1).
Health authorities have claimed that this vaccine will be effective for 5 years.
Considering this vaccine was tested for only 4 years in women 16 – 26 years of
age, I think it is important that parents are informed how this information was
generated. Parents would also like to know what ‘protection’ for 5 years
actually means. Given that we have evidence it will protect against infection
from HPV strains 16 and 18 but we have no evidence that it is the determining
factor needed for carcinomas to form (3) (4). So it may prevent some
cervical cancer (remembering that HPV does not cause cervical cancer on its own
– another co-factor is required) assuming these 2 strains (16 and 18) are
a determining factor in cancer development and assuming there is no infection
from one of the other 12 HPV viruses known to be associated with cervical cancer
development in humans (3) (4).
The US CDC claims the vaccine is ‘safe and effective’ but where is the
supportive data for this statement? Vaccine safety and efficacy studies for
Gardasil® were funded by Merck and other pharmaceutical companies. As producers
of the vaccine they have a serious conflict of interest. Consequently the public
is entitled to demand accountability and rigour in the presentation of
immunisation policies. Particularly since Merck’s chief executive officer was
quoted in 2006 claiming ‘Gardasil® was the pharmaceutical brand of the year for
building a market out of thin air’ (5).
This media hype is also supported by the fact that cervical cancer is not a
significant problem in all countries. Yet it was portrayed to women as the
“second most life-threatening cancer among women worldwide (3). In developed
nations where Pap Smear Screening Programs have been implemented cervical cancer
is a very low risk to women (3). It is almost 100% curable when it is detected
early (6) and in Australia it is listed as the 18th most common cancer in women
(5).
In addition, it remains unproven that HPV infection is the determining factor in
carcinoma development given that the majority of women are infected with HPV but
the majority of women do not get cervical cancer (3) (4). Pfister (1990)
confirms this by stating “vaccination is not yet justified as there is no formal
proof for HPV causing cancer” (8) He continues by saying that “although the
latter is certainly true, the best way to prove a necessary role of HPV in
genital cancer development would be prevention by vaccination”. This is
particularly interesting as he finishes by saying “extensive research is needed
before a vaccine will be available”. Yet Haverkos is still stating in 2005 that
many scientists admit they still do not know what the co¬factor is that is
necessary to turn HPV infection into a carcinoma (3).
Until a truly independent body is allowed to assess the data that pharmaceutical
companies are presenting to general practitioners, governments and the public,
the health of the community will continue to be at risk. We will continue to see
chronic illness increase in the population as the government spends greater
amounts of money on health. Is anybody going to argue that the primary interest
of pharmaceutical companies is women’s health or that their primary interest is
the health of the population? Pharmaceutical companies have a serious conflict
of interest and nobody is making them accountable. The public is sitting back as
Merck informs us that the 32 deaths after Gardasil® vaccination were a
coincidence. What sort of science is this? Are our children’s lives not
important enough to apply the Precautionary Principle to this vaccine – a
vaccine which is of dubious benefit?
Not only are we told that the benefits of this vaccine are not fully determined
but the public is informed that the onus is on us to prove that the vaccine has
caused these deaths. In other words, manufacturers do not have to prove the
vaccine cannot cause deaths before they use it on our daughters. Why have we
allowed the Precautionary Principle to be turned upside-down? This principle
states the ‘burden of proof of harmlessness is on the manufacturer not the
general public’. How is it that this unethical situation is allowed to
persist? We can no longer trust the government or medical practitioners to look
after public health because their decisions are influenced by financial ties to
pharmaceutical companies.
Dr. Harper’s article states that ‘Merck has confidence in the safety of
Gardasil®’. Did anyone expect Merck to say they didn’t have confidence in a
product they have spent millions of dollars investing in? Why should this
statement give us confidence in the vaccine? How confident would we feel if we
re-state it correctly as ‘Merck continues to have confidence in Gardasil’s®
safety profile as evidenced from the studies Merck has carried out and funded’.
How confident does this make us feel?
Dr. Harper reports that Lou Gehrig’s disease (Amyotrophic Lateral Sclerosis
-ALS), a progressive neurodegenerative disease that attacks motor neurons in
the brain and spinal cord has been reported after Gardasil® vaccination. It is
also reported that 32 deaths have occurred plus many serious adverse reactions.
There is a statement by Dr. Slade later in the article from the Centers for
Disease Control and Prevention (CDC), saying that a third of the possible deaths
were left out of the statistic. But instead of taking a precautionary approach
for this non-essential vaccine Merck tells us “just because patients died just
after the shots doesn’t mean the shots were necessarily to blame”. Is this for
real? Parents would like to know – and are legally entitled to know -whether the
vaccine can cause these types of reactions before the vaccines are used on our
children – not after they have been used on our children. To date Merck has made
1.4 billion dollars from this experiment (9).
Dr. Slade reports that the risk of serious events including death after gardasil
was 3.4/100,000 doses distributed. Dr. Harper then states that ‘the rate of
serious adverse events is on par with the death rate of cervical cancer’. This
figure is then corrected because the figure was determined by using the total
number of doses that were produced by the manufacturer and many of these
(one-third) are still sitting in the refrigerator waiting to be distributed.
Therefore using a smaller denominator the incidence of serious adverse events is
now 5 fold greater than the incidence of cervical cancer – which in fact varies
between countries. This measure of harm is based on the assumption that
the vaccine will prevent some cervical cancer.
In other words, we have seriously increased the amount of chronic illness and
deaths in young women without a guarantee that cervical cancer will be reduced.
Dr. Harper asks ‘how parents value this information?’ Parents are very angry
that our trust in the medical profession has been betrayed by the governments
who have not put the public interest first. Governments have allowed the
pharmaceutical companies to fund Professional Medical Associations in order to
influence the promotion of this vaccine to the public (9).
Dr. Harper goes on to say that she agrees with Merck and the CDC that this
vaccine ‘is safe for most girls’. What is this statement being based upon when
chronic illness has not been factored into the safety trials that were carried
out by Merck? The chemicals in vaccines can affect biological systems hours,
months or years after exposure (10). This vaccine contains 225 micrograms of
aluminium adjuvant which is several times more than other vaccines (1). It has
been known since 1966 that this adjuvant is linked to hypersensitivity reactions
in humans (11). The results of the trials showed numerous adverse reactions from
Gardasil® and the placebo that contained aluminium adjuvant (1). The vaccine was
also linked to autoimmune diseases in the trials, in particular an increase in
arthritis and rheumatoid arthritis (1).
A further point is made regarding the fact that the vaccine won’t protect
against 30 percent of cervical cancer. This is because there are at least 14 HPV
strains that cause 90% of cancers (12). HPV strains 16 and 18 are only
associated with 70 percent of cervical cancers in women. The following statement
by Dr. Harper about gardasil vaccination needs clarification ‘should women
believe this is preventative for all cancers – something never stated but often
implied in the population…”. The reason the public believes that Gardasil®
vaccination will protect against all cervical cancer is because that is what
they have been told in education programs in schools and through the media,
which are funded by governments and pharmaceutical companies.
The information presented to young girls did not emphasis that 30 percent of
cervical cancer was not protected by the vaccine. It was implied to women that
the vaccine would protect against all cervical cancers. This problem has arisen
because of the misinformation presented to women about this vaccine. This
information has been supported by the health departments and the medical
profession of all countries.
Dr. Harper is to be commended for speaking out. However, claiming that
Gardasil® vaccine could be a ‘miserable failure’ is understating the problem.
There’s great urgency to determine whether Gardasil® has precipitated chronic
illness and death. That determination would make it a huge public health
disaster if it is established that HPV 16 and 18 are not the determining factor
in the progression of dysplasia to cervical cancer. Public health authorities
should have required these answers before Gardasil® was promoted to women not
after the event.
Judy Wilyman
PhD Candidate
Murdoch University
Acknowledgements:
I would like to acknowledge Catherine Frompovich for her comments on the
structure of this paper and for the support of Associate Professor Peter Dingle.
References:
1. Merck and Co. 2006: GARDASIL [Quadrivalent Human Papillomavirus (Types 6, 11,
16, 18), Prescribing Information as cited in Investigate before you Vaccinate:
making an informed decision about vaccination in New Zealand, 2006, published by
Immunisation Awareness Society, New Zealand.
2. Attkisson S, 19th August 2009, CBS News, “Gardasil Vaccine Causes More Deaths
and Damage than Cancer Itself”, Interview with Dr. Diane Harper.
3. Haverkos H, 2005, Multifactorial Etiology of Cervical Cancer: A Hypothesis,
Medscape General Medicine, v 7 (4)
4. Munoz N, Castellagnue X, Berrington de Gonzales A, Gissmann L, HPV Vaccines
and Screening in the Prevention of Cervical Cancer, Ch. 1: HPV in the Etiology
of Human Cancer, 2006, Vaccine, Vol 24, Suppl. 3, 21 August, p S1-S10.
5. Herskovits B. 2007, Brand of the Year, Pharmaceutical Executive, 27 (2):
58-65
6. Schiffman M, 2002 as cited in Kircheimer S, Herpes Linked to Cervical Cancer,
WebMD HealthNews
7. Australian Government, Australian Institute of Health and Welfare (AIHW),
Facts about Cervical Cancer, 2006.
8. Pfister H (Ed.), 1990, Papillomaviruses and Human Cancer (p.248), CPR Press
Inc, Florida, USA
9. Rothman S and Rothman D, 2009, Marketing HPV Vaccine: Implications for
Adolescent Health and Medical Professionalism, JAMA August 19, Vol 302, No 7
10. Eldred BE, Dean AJ, McGuire TM, Nash AL, 2006, Vaccine Components and
constituents: responding to consumer concerns, Medical Journal of Australia,
Vol. 184 Number 4, 20th February 2006.
11. Greville, RW. , 1966, Recent and Future Development in Immunising Vaccines,
The Medical Journal of Australia, May 21, p. 908.
12. Smith J 2002 as cited in Kircheimer S Herpes Linked to Cervical Cancer,
WebMD HealthNews